Page last updated: 2024-10-15

n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

Description

N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine: structure given in first source; major adduct formed by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine with DNA [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135659020
MeSH IDM0209825

Synonyms (12)

Synonym
guanosine, 2'-deoxy-8-((1-methyl-6-phenyl-1h-imidazo(4,5-b)pyridin-2-yl)amino)-
dg-c8-phip
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
142784-25-6
dguo-phip
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-beta]pyridine
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-|a]pyridine
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-?]pyridine
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-[(1-methyl-6-phenylimidazo[4,5-b]pyridin-2-yl)amino]-1h-purin-6-one
DTXSID80931641
9-(2-deoxypentofuranosyl)-2-imino-8-[(1-methyl-6-phenyl-1h-imidazo[4,5-b]pyridin-2-yl)amino]-3,9-dihydro-2h-purin-6-ol
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5- beta ]pyridine

Dosage Studied

ExcerptReference
" After four weeks only the mice dosed with IQ and PhIP had aberrant crypt foci."( The ability of two cooked food mutagens to induce aberrant crypt foci in mice.
Kristiansen, E; Meyer, O; Thorup, I, 1997
)
" HPLC analysis of samples of urine and extracts from faeces, from rats dosed with [3H]PhIP-dG, showed that approximately 90% of the radioactivity co-eluted with PhIP-dG, indicating that PhIP-dG is excreted unmetabolized."( Excretion of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline, PhIP-dG, PhIP-DNA and DiMeIQx-DNA from the rat.
Frandsen, H, 1997
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (42.86)18.2507
2000's5 (35.71)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]